Watchlist Price Alert

ARS Pharmaceuticals Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

14.94

-0.22 (-1.45%)

At close: Jun 17, 2025, 10:12 AM

ARS Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	8M	-54.37M	-34.68M	-20.24M	-1.06M	-23.97M	-17.58M
Depreciation & Amortization	-7.17M	73K	319K	6K	6K	1.55M	1.42M
Stock-Based Compensation	14.53M	9.23M	5.84M	2.83M	3.54M	n/a	n/a
Other Working Capital	-4.12M	-4.55M	-2.47M	-6.39M	4.67M	-714K	-946K
Other Non-Cash Items	-1.81M	-6.88M	1.2M	207K	121K	-699K	2.04M
Deferred Income Tax	n/a	n/a	n/a	-4K	1K	n/a	n/a
Change in Working Capital	-1.81M	-7.33M	-12.75M	-356K	6.46M	3.3M	-433K
Operating Cash Flow	13.55M	-59.27M	-40.08M	-17.56M	9.07M	-18.9M	-16.88M
Capital Expenditures	-563K	-175K	-199K	-55K	-917K	-96K	-449K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-356.04M	-272M	n/a	-65.11M	n/a	n/a	n/a
Sales Maturities Of Investments	258M	185M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-7.5M	n/a	n/a	65.11M	n/a	n/a	n/a
Investing Cash Flow	-106.1M	-87.18M	-199K	-55K	-917K	-96K	-449K
Debt Repayment	n/a	n/a	-8.68M	-1.82M	5M	8.59M	-852K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	72.4M	6.9M	199.41M	169K	99K	n/a	n/a
Financial Cash Flow	72.4M	6.9M	190.73M	53.16M	5.1M	8.61M	19.4M
Net Cash Flow	-20.15M	-139.55M	150.46M	35.54M	14.17M	-10.18M	2.08M
Free Cash Flow	12.98M	-59.44M	-40.28M	-17.62M	8.15M	-18.99M	-17.32M